Inactive Instrument

Proto Script Pharmaceutical Corp. Stock Other OTC

PSCR

US74373V1052

Valuation: Proto Script Pharmaceutical Corp.

Market Cap	1.97M 1.73M 1.61M 1.48M 2.77M 188M 2.81M 19.12M 7.47M 93.08M 7.38M 7.22M 322M	P/E 2015 *	-	P/E 2016	-41.4x
Enterprise Value	2.01M 1.77M 1.65M 1.51M 2.84M 193M 2.88M 19.58M 7.65M 95.34M 7.56M 7.4M 330M	EV / Sales 2015 *	-	EV / Sales 2016	394x
Free-Float	89.82%	Yield 2015 *	-	Yield 2016	-

* Estimated data More valuation ratios

Latest news : Proto Script Pharmaceutical Corp.

21/04/17	Proto Script Pharmaceutical Enters Partnership with PAKmed	CI
09/11/16	Proto Script Pharmaceutical Corp. will Change its Ticker to PSCR from YNXG.D	CI
07/11/16	Proto Script Pharmaceutical Corp. Announces Management Changes	CI
13/10/16	Yanex Group, Inc. will Change its Ticker to YNXGD from YNXG	CI
09/09/16	Yanex Group, Inc. Announces Management Changes	CI
09/09/16	Yanex Group Seeks Acquisitions	CI
06/07/16	Yanex Group, Inc. Reports Unaudited Consolidated Earnings Results for the Three Months Ended March 31, 2016	CI
05/07/16	Proto-Script Pharmaceuticals, Corp. acquired Yanex Group, Inc. in a reverse merger transaction.	CI
17/03/15	Michelle Rico acquired Proto-Script Pharmaceuticals Corp. from other stockholders.	CI
23/01/15	Proto-Script Pharmaceuticals Corp. agreed to acquire 49.29% in Wolverine Holding Corp. from Coral Capital Partners, Inc. for $0.06 million.	CI

More news

Managers and Directors: Proto Script Pharmaceutical Corp.

Manager	Title	Age	Since
Michelle Rico CEO	Chief Executive Officer	58	29/06/2016

More insiders

Other Business Support Services

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
PROTO SCRIPT PHARMACEUTICAL CORP.	-.--%	-43.33%	-	-	11.38K
CINTAS CORPORATION	+2.46%	+4.55%	-4.27%	+67.26%	82.39B
RB GLOBAL, INC.	+4.27%	+5.21%	+7.25%	+82.17%	20.79B
JACOBS SOLUTIONS INC.	+0.50%	+4.43%	-5.62%	+7.39%	15.89B
BUREAU VERITAS SA	+0.33%	-1.20%	-2.13%	+7.08%	13.63B
INTERTEK GROUP PLC	+0.26%	+0.26%	+18.79%	+37.52%	11.92B
ALS LIMITED	+3.91%	-3.19%	+17.65%	+88.14%	7.26B
ISS A/S	+0.62%	+0.48%	+52.89%	+110.34%	6.91B
UNIFIRST CORPORATION	+1.06%	+2.44%	+70.95%	+91.63%	5.32B
GENPACT LIMITED	+2.94%	+5.03%	-28.99%	-13.24%	5.3B
Average	+1.64%	-0.39%	+14.06%	+53.14%	18.82B
Weighted average by Cap.	+2.13%	+0.19%	+3.68%	+57.44%

See all sector performances

Proto-Script Pharmaceuticals, Corp., formerly Yanex Group, Inc. is a development-stage company. The Company is primarily in the business of repair power wheelchairs and scooters, which are classified as durable medical equipment (DME) products and reimbursable by healthcare insurance providers. The Company has various contracts with state and governmental insurance providers, among others. These contracts provide the Company the right to sell and repair DME. The Company's health care insurance contracts allow it the ability to service patients nationally. The Company intends to expand its market through additional contracts and open several repair facilities throughout the continental United States. The Company currently has repair facilities in Las Vegas, Nevada, Rancho-Cucamonga, and Anaheim, California. As of June 30, 2016, the Company had not generated any revenues.

Employees

Sector

Business Support Services

More about the company

As early as today, start finding the best investment opportunities!

	2015	2016
Net sales	881K 775K 721K 662K 1.24M 84.53M 1.26M 8.57M 3.35M 41.74M 3.31M 3.24M 144M	789K 694K 646K 593K 1.11M 75.66M 1.13M 7.67M 3M 37.36M 2.96M 2.9M 129M
Net income	-145K -128K -119K -109K -205K -13.93M -208K -1.41M -552K -6.88M -545K -533K -23.77M	-7.18M -6.31M -5.88M -5.4M -10.14M -689M -10.27M -69.87M -27.29M -340M -26.96M -26.38M -1.18B
Net Debt	27.07K 23.8K 22.15K 20.34K 38.2K 2.6M 38.7K 263K 103K 1.28M 102K 99.42K 4.43M	47.78K 42.01K 39.1K 35.91K 67.43K 4.58M 68.32K 465K 182K 2.26M 179K 176K 7.82M